Publication & Citation Trends
Most Cited Works
Publications
496 total
1979P Randomized, open-label, phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone in chemotherapy-naïve patients with ALK-positive non-squamous non-small cell lung cancer: Interim safety analysis of the WJOG14720L
Cited by 0
Semantic Scholar
EP.13.14 Real-World Data Analysis of Treatment Pattern and Prognosis of Patients With Limited-Stage Small Cell Lung Cancer in Japan
Cited by 0
Semantic Scholar
1958P ONO-7475 phase I study: An open-label, uncontrolled study of ONO-7475 in combination with osimertinib in EGFR mutated advanced non-small cell lung cancer
Cited by 0
Semantic Scholar
Long-Term Safety and Effectiveness of Durvalumab in Unresectable Stage III non-small cell lung cancer in Japan: A Multicenter Prospective Study (AYAME).
Cited by 1
Semantic Scholar
P3.03.42 Immune-Related Gene Expression Profiling and ALK-TKI Efficacy for Patients With ALK-Rearranged Non-Small Cell Cancer
Cited by 0
Semantic Scholar
119P: Real-world first-line (1L) treatment characteristics and physician-reported areas of improvement for patients with advanced non-small cell lung cancer (aNSCLC) with PD-L1 expression ≥50% and without actionable genomic alternations (AGA) in Europe (EU), United States (US) and Asia
Cited by 0
Semantic Scholar
1065P Prognostic clinical phenotypes in pulmonary large cell neuroendocrine carcinoma (LCNEC): Multi-center, observational study
Cited by 0
Semantic Scholar
EP.17.32 Real-World Disease Impact in First-Line Treated Patients With Advanced Non-Small Cell Lung Cancer With PD-L1 Expression =50%
Cited by 1
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(254)
Lung Cancer Research Studies
(137)
Lung Cancer Diagnosis and Treatment
(95)
Cancer Genomics and Diagnostics
(81)
Gastrointestinal Tumor Research and Treatment
(80)
Frequent Co-Authors
Affiliations
Toho University
Fukushima Medical University
University of Tsukuba
Keio University
Fujisawa City Hospital